Sunesis Pharmaceuticals
South San Francisco
About Sunesis Pharmaceuticals
Sunesis is an emerging biopharmaceutical company creating new medicines to improve the lives of people with cancer. They are building a pipeline of drugs that selectively block critical mechanisms required for tumor growth and survival. The fight against cancer is an enormous mission that requires an integrated approach fueled by a commitment to innovation.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $221.7M
- Funding stage: M&A
- Last round: Post-IPO Equity (Oct 2016)
- Ticker: nasdaq:SNSS
- Website: sunesis.com
- Phone: 650) 266-3500
Industries & Categories
Biotechnology, Health Care, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/sunesis-pharmaceuticals-215660 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.